Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Sintana Energy flags major resource upgrade at Namibia oil discovery - 2Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
- 3Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- 4The Best Music Collections of the 10 years
- 5German politician urges more face-to-face interaction in digital age
- Get To Be familiar with The Historical backdrop Of Western Medication
- Land Rover Just Unveiled Its Dakar Rally Defender
- The secret appeal of Harlan Coben’s messy, addictive TV thrillers
- Aluminum salts emerge as likely target as health officials scrutinize childhood vaccines
- 6 Home Cleaning Administrations to Keep Your Home Unblemished
- The Electric Bicycle Americans Can Confide in 2024
- Rubble, mud and hair: How to rebuild a home in Gaza
- Experience Is standing by: History's Most noteworthy Travelers
- Protester climbs on to balcony of Iranian embassy in London
